Advertisement
International
Subscribe to International
View Sample

FREE Email Newsletter

$3.6 million research project underway to reduce mother and baby deaths in Malawi

March 2, 2011 8:37 am | by EurekAlert | News | Comments

(University of Warwick) Warwick Medical School has just begun a ?2.6 ($3.6) million three year research and training program to train Malawian clinical officers in a bid to reduce the country's high death rate for pregnant mothers and babies.

Effectiveness of wastewater treatment may be damaged during a severe flu pandemic

March 1, 2011 8:40 pm | by EurekAlert | News | Comments

(Centre for Ecology & Hydrology) Existing plans for antiviral and antibiotic use during a severe influenza pandemic could reduce wastewater treatment efficiency prior to discharge into receiving rivers, resulting in water quality deterioration at drinking water abstraction points,...

New report says large proportion of colorectal cancer deaths could be prevented

March 1, 2011 1:36 pm | by EurekAlert | News | Comments

(American Cancer Society) A new report from the American Cancer Society says a large proportion of the 141,000 cases and 49,000 deaths from colorectal cancer expected in the United States this year could be prevented by increasing the use of established screening tests and by...

Advertisement

Colliers reports slight drop in life sciences vacancy rate

March 1, 2011 10:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Real estate firm Colliers International has released its semi-annual review of the Greater Boston life sciences sector and real estate trends in that market, noting that there are about 500 biotech companies in Massachusetts and 40 local colleges and universities offering advanced degrees...

Genzyme completes pharmaceutical unit sale

March 1, 2011 10:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Genzyme Corp. has completed the divestiture of its pharmaceutical intermediates business to International Chemical Investors Group – a plan the Cambridge company announced early in February.

Global ISU study: Invasive species widespread, but not more than at home range

March 1, 2011 10:38 am | by EurekAlert | News | Comments

(Iowa State University) Invasive plant species have long had a reputation as being bad for a new ecosystem when they are introduced. As it turns out, they aren't any more abundant away from home than they are at home.

Spontaneous smoking cessation may be an early symptom of lung cancer, research suggests

March 1, 2011 7:38 am | by EurekAlert | News | Comments

(International Association for the Study of Lung Cancer) Many longtime smokers quit spontaneously with little effort shortly before their lung cancer is diagnosed, leading some researchers to speculate that sudden cessation may be a symptom of lung cancer.

CROI -- Day 2: Selected highlights of NIH-supported research

March 1, 2011 7:37 am | by EurekAlert | News | Comments

(NIH/National Institute of Allergy and Infectious Diseases) The 18th Conference on Retroviruses and Opportunistic Infections is taking place at the Hynes Convention Center in Boston from Feb. 27 through March 2. Day two of this major HIV/AIDS research conference included the...

Advertisement

Watchful waiting no longer recommended for some high-risk Barrett's esophagus patients

March 1, 2011 6:39 am | by EurekAlert | News | Comments

(American Gastroenterological Association) Endoscopic removal of pre-cancerous cells in patients with confirmed, high-risk Barrett's esophagus is recommended rather than surveillance, according to a new "Medical Position Statement on the Management of Barrett's Esophagus,"...

Top scientists unite to develop global scientific strategy Towards An HIV Cure

February 28, 2011 10:38 am | by EurekAlert | News | Comments

(International AIDS Society) More than 30 scientists gathered for a one-day meeting prior to the 18th Conference on Retroviruses and Opportunistic Infections to launch an international working group on HIV reservoirs and strategies to control them. Under the auspices of the...

Caprotec bioanalytics lands patent grant

February 28, 2011 8:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Caprotec bioanalytics GmbH, a Berlin-based biotechnology company with a subsidiary in Burlington, said Monday that the European Patent Office has granted the last of three core patents for its capture compound mass spectrometry technology.

Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue

February 28, 2011 5:39 am | by EurekAlert | News | Comments

(Microbicide Trials Network) In the first head-to-head study of tenofovir gel and oral tenofovir -- two promising approaches for preventing HIV in women -- researchers found daily use of the vaginal gel achieved a more than 100-times higher concentration of active drug in vaginal...

Gene fuelled transporter causes breast cancer cells to self-destruct

February 27, 2011 9:35 pm | by EurekAlert | News | Comments

(Queen's University Belfast) Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, minuscule gene transport system, according to research published Feb. 28 in the...

Advertisement

University of Miami scientists track great hammerhead shark migration

February 27, 2011 8:34 pm | by EurekAlert | News | Comments

(University of Miami Rosenstiel School of Marine & Atmospheric Science) A study led by Neil Hammerschlag at the University of Miami details the first scientific research to successfully track a great hammerhead shark using satellite tag technology.

Canada's role grows amid looming world water shortages in some places, more flooding in others

February 27, 2011 10:34 am | by EurekAlert | News | Comments

(Canadian Water Network) With a view to UN World Water Day, March 22, experts convening in Ottawa Feb. 28 to March 3 say water-rich Canada and water management experts have growing importance as countries elsewhere brace for more frequent drought, flood and unsafe water problems...

Viral infection not responsible for exacerbation of lung disease in most patients

February 25, 2011 7:39 am | by EurekAlert | News | Comments

(American Thoracic Society) Acute viral infection does not appear to be a primary cause of acute exacerbation of idiopathic pulmonary fibrosis, a progressive, deadly disease resulting in thickening and scarring of the lungs, according to a study conducted by researchers from the...

New way to identify patients at risk of dysphagia after head and neck cancer treatment

February 25, 2011 7:39 am | by EurekAlert | News | Comments

(European Society for Medical Oncology) At the 3rd International Conference on innovative approaches in Head and Neck Oncology, Dr. Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7...

Little historical evidence to support cutting global health aid during recessions

February 25, 2011 7:39 am | by EurekAlert | News | Comments

(Harvard School of Public Health) According to a new study from the Harvard School of Public Health, there is surprisingly little historical evidence to justify reversing global financial aid commitments.

Quick, easy test identifies aggressive type of lung cancer in never-smokers

February 24, 2011 9:37 pm | by EurekAlert | News | Comments

(European Society for Medical Oncology) An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found

Oncogene AEG-1 strongly predicts response to erlotinib treatment in EGFR-mutant lung cancer

February 24, 2011 9:37 pm | by EurekAlert | News | Comments

(European Society for Medical Oncology) Spanish researchers have identified a gene whose expression level strongly predicts how well certain lung cancer patients will respond to treatment with the drug erlotinib.

Brain imaging provides window into consciousness

February 24, 2011 7:37 pm | by EurekAlert | News | Comments

(New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College) Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness -- but the view it presents is one...

Hospital infections and multidrug-resistant pathogens(2)

February 24, 2011 11:38 am | by EurekAlert | News | Comments

(Deutsches Aerzteblatt International) Infections are among the most frequent complications of a stay in hospital and raise the complication and mortality rates. Calculations based on data from the Hospital Infection Surveillance System showed an incidence of almost 60 000 newly...

Elderly patients admitted with high glucose levels are more likely to die in hospital

February 24, 2011 10:40 am | by EurekAlert | News | Comments

(Wiley-Blackwell) A two-country hospital study of 808 elderly patients found a strong association between high, undiagnosed blood glucose in non-diabetic patients and increased hospital death rates. Researchers are now calling for routine blood glucose testing of elderly patients...

IOF calls for action following release of Eastern European & Central Asian Regional Audit

February 24, 2011 10:40 am | by EurekAlert | News | Comments

(International Osteoporosis Foundation) An audit report by the International Osteoporosis Foundation consolidates information on the status and burden of osteoporosis in 21 countries of Eastern Europe and Central Asia, including the Russian Federation. The publication includes...

Infinity Pharmaceuticals begins enrolling for pancreatic cancer drug trial

February 24, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Infinity Pharmaceuticals Inc. of Cambridge is moving forward with the first drug candidate stemming from its $75 million alliance with Purdue Pharmaceutical Products LP of Stamford, Conn., and Mundipharma International Corporation Ltd. of the UK.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading